In vivo production of novel vitamin D2 hydroxy-derivatives by human placentas, epidermal keratinocytes, Caco-2 colon cells and the adrenal gland

A.T. Słomiński, T. Kim, H.Z. Shehabi, E.K.Y. Tang, H.A.E. Benson, I.V. Semak, Z. Lin, C.R. Yates, J. Wang, W. Li., Robert Tuckey

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

We investigated the metabolism of vitamin D2 to hydroxyvitamin D2 metabolites ((OH)D2) by human placentas ex-utero, adrenal glands ex-vivo and cultured human epidermal keratinocytes and colonic Caco-2 cells, and identified 20(OH)D2, 17,20(OH)2D2, 1,20(OH)2D2, 25(OH)D2 and 1,25(OH)2D2 as products. Inhibition of product formation by 22R-hydroxycholesterol indicated involvement of CYP11A1 in 20- and 17-hydroxylation of vitamin D2, while use of ketoconazole indicated involvement of CYP27B1 in 1α-hydroxylation of products. Studies with purified human CYP11A1 confirmed the ability of this enzyme to convert vitamin D2 to 20(OH)D2 and 17,20(OH)2D2. In placentas and Caco-2 cells, production of 20(OH)D2 was higher than 25(OH)D2 while in human keratinocytes the production of 20(OH)D2 and 25(OH)D2 were comparable. HaCaT keratinocytes showed high accumulation of 1,20(OH)2D2 relative to 20(OH)D2 indicating substantial CYP27B1 activity. This is the first in vivo evidence for a novel pathway of vitamin D2 metabolism initiated by CYP11A1 and modified by CYP27B1, with the product profile showing tissue- and cell-type specificity. © 2014 Elsevier Ireland Ltd.
Original languageEnglish
Pages (from-to)181-192
JournalMolecular and Cellular Endocrinology
Volume383
Issue number1-2
DOIs
Publication statusPublished - 2014

Fingerprint

Ergocalciferols
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
Caco-2 Cells
Cholesterol Side-Chain Cleavage Enzyme
Adrenal Glands
Keratinocytes
Placenta
Colon
Derivatives
Hydroxylation
Metabolism
Organ Specificity
Ketoconazole
Metabolites
Ireland
Tissue
Enzymes

Cite this

Słomiński, A.T. ; Kim, T. ; Shehabi, H.Z. ; Tang, E.K.Y. ; Benson, H.A.E. ; Semak, I.V. ; Lin, Z. ; Yates, C.R. ; Wang, J. ; Li., W. ; Tuckey, Robert. / In vivo production of novel vitamin D2 hydroxy-derivatives by human placentas, epidermal keratinocytes, Caco-2 colon cells and the adrenal gland. In: Molecular and Cellular Endocrinology. 2014 ; Vol. 383, No. 1-2. pp. 181-192.
@article{ce390dcde51146e5ba950052c372ce3c,
title = "In vivo production of novel vitamin D2 hydroxy-derivatives by human placentas, epidermal keratinocytes, Caco-2 colon cells and the adrenal gland",
abstract = "We investigated the metabolism of vitamin D2 to hydroxyvitamin D2 metabolites ((OH)D2) by human placentas ex-utero, adrenal glands ex-vivo and cultured human epidermal keratinocytes and colonic Caco-2 cells, and identified 20(OH)D2, 17,20(OH)2D2, 1,20(OH)2D2, 25(OH)D2 and 1,25(OH)2D2 as products. Inhibition of product formation by 22R-hydroxycholesterol indicated involvement of CYP11A1 in 20- and 17-hydroxylation of vitamin D2, while use of ketoconazole indicated involvement of CYP27B1 in 1α-hydroxylation of products. Studies with purified human CYP11A1 confirmed the ability of this enzyme to convert vitamin D2 to 20(OH)D2 and 17,20(OH)2D2. In placentas and Caco-2 cells, production of 20(OH)D2 was higher than 25(OH)D2 while in human keratinocytes the production of 20(OH)D2 and 25(OH)D2 were comparable. HaCaT keratinocytes showed high accumulation of 1,20(OH)2D2 relative to 20(OH)D2 indicating substantial CYP27B1 activity. This is the first in vivo evidence for a novel pathway of vitamin D2 metabolism initiated by CYP11A1 and modified by CYP27B1, with the product profile showing tissue- and cell-type specificity. {\circledC} 2014 Elsevier Ireland Ltd.",
author = "A.T. Słomiński and T. Kim and H.Z. Shehabi and E.K.Y. Tang and H.A.E. Benson and I.V. Semak and Z. Lin and C.R. Yates and J. Wang and W. Li. and Robert Tuckey",
year = "2014",
doi = "10.1016/j.mce.2013.12.012",
language = "English",
volume = "383",
pages = "181--192",
journal = "Molecular and Cellular Endocrinology",
issn = "0303-7207",
publisher = "Elsevier",
number = "1-2",

}

In vivo production of novel vitamin D2 hydroxy-derivatives by human placentas, epidermal keratinocytes, Caco-2 colon cells and the adrenal gland. / Słomiński, A.T.; Kim, T.; Shehabi, H.Z.; Tang, E.K.Y.; Benson, H.A.E.; Semak, I.V.; Lin, Z.; Yates, C.R.; Wang, J.; Li., W.; Tuckey, Robert.

In: Molecular and Cellular Endocrinology, Vol. 383, No. 1-2, 2014, p. 181-192.

Research output: Contribution to journalArticle

TY - JOUR

T1 - In vivo production of novel vitamin D2 hydroxy-derivatives by human placentas, epidermal keratinocytes, Caco-2 colon cells and the adrenal gland

AU - Słomiński, A.T.

AU - Kim, T.

AU - Shehabi, H.Z.

AU - Tang, E.K.Y.

AU - Benson, H.A.E.

AU - Semak, I.V.

AU - Lin, Z.

AU - Yates, C.R.

AU - Wang, J.

AU - Li., W.

AU - Tuckey, Robert

PY - 2014

Y1 - 2014

N2 - We investigated the metabolism of vitamin D2 to hydroxyvitamin D2 metabolites ((OH)D2) by human placentas ex-utero, adrenal glands ex-vivo and cultured human epidermal keratinocytes and colonic Caco-2 cells, and identified 20(OH)D2, 17,20(OH)2D2, 1,20(OH)2D2, 25(OH)D2 and 1,25(OH)2D2 as products. Inhibition of product formation by 22R-hydroxycholesterol indicated involvement of CYP11A1 in 20- and 17-hydroxylation of vitamin D2, while use of ketoconazole indicated involvement of CYP27B1 in 1α-hydroxylation of products. Studies with purified human CYP11A1 confirmed the ability of this enzyme to convert vitamin D2 to 20(OH)D2 and 17,20(OH)2D2. In placentas and Caco-2 cells, production of 20(OH)D2 was higher than 25(OH)D2 while in human keratinocytes the production of 20(OH)D2 and 25(OH)D2 were comparable. HaCaT keratinocytes showed high accumulation of 1,20(OH)2D2 relative to 20(OH)D2 indicating substantial CYP27B1 activity. This is the first in vivo evidence for a novel pathway of vitamin D2 metabolism initiated by CYP11A1 and modified by CYP27B1, with the product profile showing tissue- and cell-type specificity. © 2014 Elsevier Ireland Ltd.

AB - We investigated the metabolism of vitamin D2 to hydroxyvitamin D2 metabolites ((OH)D2) by human placentas ex-utero, adrenal glands ex-vivo and cultured human epidermal keratinocytes and colonic Caco-2 cells, and identified 20(OH)D2, 17,20(OH)2D2, 1,20(OH)2D2, 25(OH)D2 and 1,25(OH)2D2 as products. Inhibition of product formation by 22R-hydroxycholesterol indicated involvement of CYP11A1 in 20- and 17-hydroxylation of vitamin D2, while use of ketoconazole indicated involvement of CYP27B1 in 1α-hydroxylation of products. Studies with purified human CYP11A1 confirmed the ability of this enzyme to convert vitamin D2 to 20(OH)D2 and 17,20(OH)2D2. In placentas and Caco-2 cells, production of 20(OH)D2 was higher than 25(OH)D2 while in human keratinocytes the production of 20(OH)D2 and 25(OH)D2 were comparable. HaCaT keratinocytes showed high accumulation of 1,20(OH)2D2 relative to 20(OH)D2 indicating substantial CYP27B1 activity. This is the first in vivo evidence for a novel pathway of vitamin D2 metabolism initiated by CYP11A1 and modified by CYP27B1, with the product profile showing tissue- and cell-type specificity. © 2014 Elsevier Ireland Ltd.

U2 - 10.1016/j.mce.2013.12.012

DO - 10.1016/j.mce.2013.12.012

M3 - Article

VL - 383

SP - 181

EP - 192

JO - Molecular and Cellular Endocrinology

JF - Molecular and Cellular Endocrinology

SN - 0303-7207

IS - 1-2

ER -